An analysis of the PURE study shows some gains but “little to no improvement in most places over time,” says Philip Joseph.

The IRA measure is a good first step, but some are looking even further ahead to GLP-1 price drops to increase access.

A new study comparing multiple and single arterial grafting highlights how physician preference can bias observational data.

Sreekanth Vemulapalli asks Ryan Ahern about potential data sources that can be used to sustain long-term follow-up in pivotal ...

January saw almost every major cardiovascular subspecialty represented among our most-clicked stories of the month.

An early pioneer in the interventional community, Hildner advocated for sharing experiences to improve patient outcomes.